Nicholas Yang is a Senior Associate at Tourmaline Bio with previous experience as an Analyst at Roivant Sciences. Nicholas has a strong background in research, particularly in the field of chimeric antigen receptor (CAR) T cell therapy, and has worked on various projects to enhance the efficacy of cancer treatments. Nicholas holds a Bachelor's degree in Economics, Finance, and Behavioral Economics, as well as a Bachelor's degree in Biology.
January, 2024 - present
February, 2023